MOTRIFLEX naproxen sodium 275 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

motriflex naproxen sodium 275 mg tablet blister pack

johnson & johnson pacific pty ltd - naproxen sodium, quantity: 275 mg - tablet, film coated - excipient ingredients: maize starch; crospovidone; hypromellose; colloidal anhydrous silica; iron oxide yellow; macrogol 400; magnesium stearate; purified talc; indigo carmine; titanium dioxide; povidone - provides temporary relief of pain and/or inflammation associated with muscular aches and pains, sprains and strains, backache, osteoarthritis, rheumatic pain, arthritis, headache, period pain, dental pain and cold & flu. reduces fever.

MOTRIFLEX (new formula) naproxen 250 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

motriflex (new formula) naproxen 250 mg tablet blister pack

johnson & johnson pacific pty ltd - naproxen, quantity: 250 mg - tablet, uncoated - excipient ingredients: pregelatinised maize starch; croscarmellose sodium; povidone; magnesium stearate; purified water; lactose monohydrate - provides temporary relief of pain and/or inflammation associated with muscular aches and pains, sprains and strains, backache, osteoarthritis, rheumatic pain, arthritis, headache, period pain, dental pain and cold & flu. reduces fever.

Triflexa 500 mg/ 25 mg/ 2 mg Tablet Philippines - English - FDA (Food And Drug Administration)

triflexa 500 mg/ 25 mg/ 2 mg tablet

n/a; importer: n/a; distributor: curecare pharmaceutical products distribution - paracetamol , phenylpropanolamine hydrochloride , chlorphenamine maleate - tablet - 500 mg/ 25 mg/ 2 mg

TERUFLEX BLOOD BAG SYSTEM ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND OPTISOL RED CELL PRESERVATIVE (anticoagulant citrat United States - English - NLM (National Library of Medicine)

teruflex blood bag system anticoagulant citrate phosphate dextrose (cpd) and optisol red cell preservative (anticoagulant citrat

terumo corporation - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, unspecified form (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - trisodium citrate dihydrate 26.3 g in 1000 ml - teruflex® blood bag system cpd/optisol® solution blood bag system read these instructions carefully before use. rx only. intended use collection of 250 ml whole blood: • from elderly, pediatric, or smaller autologous donors who may not tolerate larger blood collections. • for blood collections as directed by a patient's physician. • platelets prepared from 250 ml whole blood collections can only be used for the autologous donation patient. • platelet preparation from a 250 ml whole blood collection are unlikely to meet the 5.5x1010 platelet concentration required by the regulations. instructions for blood collection: use aseptic technique 1. confirm that all numbered tubing of each blood bag unit contains its own identical segment numbers. 2. make a loose knot in the donor tubing approximately 10 cm from the needle. 3. clamp donor tubing with hemastat. 4. suspend primary bag a minimum of 60 cm below the donor's arm 5. apply blood pressure cuff. disinfect site of phlebotomy. inf

TERUFLEX BLOOD BAG SYSTEM WITH DIVERSION BLOOD SAMPLING ARM ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND OPTISOL (AS-5) RE United States - English - NLM (National Library of Medicine)

teruflex blood bag system with diversion blood sampling arm anticoagulant citrate phosphate dextrose (cpd) and optisol (as-5) re

terumo corporation - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, unspecified form (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - trisodium citrate dihydrate 26.3 g in 1000 ml - issued 6/03 teruflex® blood bag system with diversion blood sampling arm® cpd/optisol® solution read these instructions carefully before use. rx only. the diversion blood sampling arm™ is intended to divert and collect blood for obtaining donor test samples. • for single use only. sterile and non-pyrogenic fluid path. sterilized by steam. • intended for the collection, processing and preservation of human blood and components. precautions • do not use unless the solutions are clear. • avoid excessive heat and direct sunlight. protect from freezing. • recommended storage conditions: room temperature (15-30°c/59-86°f). • the blood bag configuration is specified on the blister pack label. caution do not use a dielectric tube sealer to seal the tubing while the needle is connected to the donor's body unless it is approved for such a purpose. instructions for blood collection: use aseptic technique materials needed: venoject® ll tube holder (code p-1316r) or eq

TERUFLEX BLOOD BAG SYSTEM WITH BLOOD SAMPLING ARM ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND OPTISOL (AS-5) RED CELL PRE United States - English - NLM (National Library of Medicine)

teruflex blood bag system with blood sampling arm anticoagulant citrate phosphate dextrose (cpd) and optisol (as-5) red cell pre

terumo corporation - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, unspecified form (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - trisodium citrate dihydrate 26.3 g in 1000 ml - issued 8/96 teruflex® blood bag system with blood sampling arm® cpd/optisol® solution read these instructions carefully before use. instructions for blood collection: use aseptic technique materials needed: venoject® ll tube holder (code p-1316r) venoject® ll multi-sample luer adapter (code mn *2000) venoject® ll plastic blood collection tubes (or equivalent glass or plastic evacuated blood collection tube) 1. confirm that all numbered tubing of each blood bag unit contains segment numbers. 2. make a loose knot in donor tubing below "y" unless alternate methods are used to seal tubing. 3. clamp donor tubing. 4. suspend primary bag as far as possible below the donor's arm. 5. apply blood pressure cuff or tourniquet to donor's arm. disinfect site of phlebotomy. if blood pressure cuff is used, inflate cuff to approximately 60 mmhg. 6. remove needle protector and perform phlebotomy. remove clamp to permit blood flow into primary bag. caution do not touch needle aft

TERUFLEX BLOOD BAG SYSTEM ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND OPTISOL RED CELL PRESERVATIVE (anticoagulant citrat United States - English - NLM (National Library of Medicine)

teruflex blood bag system anticoagulant citrate phosphate dextrose (cpd) and optisol red cell preservative (anticoagulant citrat

terumo corporation - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, unspecified form (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - trisodium citrate dihydrate 26.3 g in 1000 ml - revised 8/96 teruflex® blood bag system cpd/optisol® solution read these instructions before use. instructions for blood collection: use aseptic technique 1. confirm that all numbered tubing of each blood bag unit contains segment numbers. 2. make a loose knot in the donor tubing approximately 10 cm from needle unless alternate methods are used to seal tubing. 3. clamp donor tubing. 4. suspend primary bag as far as possible below the donor's arm. 5. apply blood pressure cuff or tourniquiet to donor's arm. disinfect site of phlebotomy. if blood pressure cuff is used, inflate cuff to 60 mmhg. 6. remove needle protector and perform phlebotomy. remove clamp to permit blood flow into primary bag. caution do not touch needle after removing the needle protector. 7. appropriately secure donor tubing to donor's arm. 8. mix blood with anticoagulant at several intervals during collection. 9. collect labeled volume of blood (+/- 10%). 10. tighten knot firmly after collection. clamp betwe

TERUFLEX BLOOD BAG SYSTEM WITH BLOOD SAMPLING ARM ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND OPTISOL (AS-5) RED CELL PRE United States - English - NLM (National Library of Medicine)

teruflex blood bag system with blood sampling arm anticoagulant citrate phosphate dextrose (cpd) and optisol (as-5) red cell pre

terumo corporation - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, unspecified form (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - trisodium citrate dihydrate 26.3 g in 1000 ml - issued 8/96 teruflex® blood bag system with blood sampling arm® cpd/optisol® solution read these instructions carefully before use. instructions for blood collection: use aseptic technique materials needed: venoject® ll tube holder (code p-1316r) venoject® ll multi-sample luer adapter (code mn *2000) venoject® ll plastic blood collection tubes (or equivalent glass or plastic evacuated blood collection tube) 1. confirm that all numbered tubing of each blood bag unit contains segment numbers. 2. make a loose knot in donor tubing below "y" unless alternate methods are used to seal tubing. 3. clamp donor tubing. 4. suspend primary bag as far as possible below the donor's arm. 5. apply blood pressure cuff or tourniquet to donor's arm. disinfect site of phlebotomy. if blood pressure cuff is used, inflate cuff to approximately 60 mmhg. 6. remove needle protector and perform phlebotomy. remove clamp to permit blood flow into primary bag. caution do not touch needle aft

TERUFLEX BLOOD BAG SYSTEM WITH DIVERSION BLOOD SAMPLING ARM ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND OPTISOL (AS-5) RE United States - English - NLM (National Library of Medicine)

teruflex blood bag system with diversion blood sampling arm anticoagulant citrate phosphate dextrose (cpd) and optisol (as-5) re

terumo corporation - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - issued 6/03 teruflex® blood bag system with diversion blood sampling arm® cpd/optisol® solution read these instructions carefully before use. rx only. the diversion blood sampling arm™ is intended to divert and collect blood for obtaining donor test samples. • for single use only. sterile and non-pyrogenic fluid path. sterilized by steam. • intended for the collection, processing and preservation of human blood and components. precautions • do not use unless the solutions are clear. • avoid excessive heat and direct sunlight. protect from freezing. • recommended storage conditions: room temperature (15-30°c/59-86°f). • the blood bag configuration is specified on the blister pack label. caution do not use a dielectric tube sealer to seal the tubing while the needle is connected to the donor's body unless it is approved for such a purpose. instructions for blood collection: use aseptic technique materials needed: venoject® ll tube holder (code p-1316r) or eq

TERUFLEX BLOOD BAG SYSTEM WITH DIVERSION BLOOD SAMPLING ARM ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND OPTISOL (AS-5) RE United States - English - NLM (National Library of Medicine)

teruflex blood bag system with diversion blood sampling arm anticoagulant citrate phosphate dextrose (cpd) and optisol (as-5) re

terumo corporation - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, unspecified form (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - issued 6/03 teruflex® blood bag system with diversion blood sampling arm® cpd/optisol® solution read these instructions carefully before use. rx only. the diversion blood sampling arm™ is intended to divert and collect blood for obtaining donor test samples. • for single use only. sterile and non-pyrogenic fluid path. sterilized by steam. • intended for the collection, processing and preservation of human blood and components. precautions • do not use unless the solutions are clear. • avoid excessive heat and direct sunlight. protect from freezing. • recommended storage conditions: room temperature (15-30°c/59-86°f). • the blood bag configuration is specified on the blister pack label. caution do not use a dielectric tube sealer to seal the tubing while the needle is connected to the donor's body unless it is approved for such a purpose. instructions for blood collection: use aseptic technique materials needed: venoject® ll tube holder (code p-1316r) or eq